Head to Head Analysis: DENTSPLY SIRONA (NASDAQ:XRAY) vs. Spotlight Innovation (OTCMKTS:STLT)

Spotlight Innovation (OTCMKTS:STLT) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Spotlight Innovation and DENTSPLY SIRONA, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spotlight Innovation	0	0	0	0	0.00
DENTSPLY SIRONA	0	11	2	0	2.15

DENTSPLY SIRONA has a consensus target price of $18.64, indicating a potential upside of 43.80%. Given DENTSPLY SIRONA’s stronger consensus rating and higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than Spotlight Innovation.

Earnings and Valuation

This table compares Spotlight Innovation and DENTSPLY SIRONA”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spotlight Innovation	N/A	N/A	N/A	N/A	N/A
DENTSPLY SIRONA	$3.67 billion	0.70	-$910.00 million	($4.74)	-2.73

Spotlight Innovation has higher earnings, but lower revenue than DENTSPLY SIRONA.

Insider & Institutional Ownership

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Spotlight Innovation and DENTSPLY SIRONA’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spotlight Innovation	N/A	N/A	N/A
DENTSPLY SIRONA	-25.85%	16.33%	5.60%

Summary

DENTSPLY SIRONA beats Spotlight Innovation on 8 of the 9 factors compared between the two stocks.

About Spotlight Innovation

Spotlight Innovation Inc., a pharmaceutical company, acquires and develops proprietary therapies to address unmet medical needs with an emphasis on rare, emerging, and neglected diseases. It identifies in-licensing opportunities and manages product development through partnerships with universities, medical schools, contract research organizations, and contract manufacturing organizations, as well as pursues product commercialization opportunities, including out-licensing and strategic partnerships. The company is developing Crotoxin, which is in Phase I clinical study for the treatment of cancer. It also develops various compounds for the treatment of viral infections, including Zika virus infection; and products derived from cobra venom to treat chronic pain. Spotlight Innovation Inc. has a license agreement with Indiana University Research and Technology Corporation to commercialize STL-182, an orally-available small molecule that might have therapeutic potential for treating spinal muscular atrophy. The company is based in Urbandale, Iowa.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina